S&P 500   4,590.72 (+0.11%)
DOW   36,157.16 (+0.11%)
QQQ   391.15 (+0.18%)
AAPL   194.71 (+0.23%)
MSFT   372.45 (+0.40%)
META   329.58 (+0.92%)
GOOGL   135.05 (-1.37%)
AMZN   146.56 (-0.22%)
TSLA   243.59 (+0.39%)
NVDA   475.58 (+2.06%)
NIO   7.48 (-0.13%)
BABA   72.12 (-0.29%)
AMD   129.15 (+0.61%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.53 (+1.19%)
CGC   0.76 (+5.07%)
GE   120.00 (+0.44%)
DIS   93.03 (+0.74%)
AMC   7.01 (+2.79%)
PFE   28.83 (+0.70%)
PYPL   59.37 (+1.52%)
XOM   99.22 (+0.81%)
S&P 500   4,590.72 (+0.11%)
DOW   36,157.16 (+0.11%)
QQQ   391.15 (+0.18%)
AAPL   194.71 (+0.23%)
MSFT   372.45 (+0.40%)
META   329.58 (+0.92%)
GOOGL   135.05 (-1.37%)
AMZN   146.56 (-0.22%)
TSLA   243.59 (+0.39%)
NVDA   475.58 (+2.06%)
NIO   7.48 (-0.13%)
BABA   72.12 (-0.29%)
AMD   129.15 (+0.61%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.53 (+1.19%)
CGC   0.76 (+5.07%)
GE   120.00 (+0.44%)
DIS   93.03 (+0.74%)
AMC   7.01 (+2.79%)
PFE   28.83 (+0.70%)
PYPL   59.37 (+1.52%)
XOM   99.22 (+0.81%)
S&P 500   4,590.72 (+0.11%)
DOW   36,157.16 (+0.11%)
QQQ   391.15 (+0.18%)
AAPL   194.71 (+0.23%)
MSFT   372.45 (+0.40%)
META   329.58 (+0.92%)
GOOGL   135.05 (-1.37%)
AMZN   146.56 (-0.22%)
TSLA   243.59 (+0.39%)
NVDA   475.58 (+2.06%)
NIO   7.48 (-0.13%)
BABA   72.12 (-0.29%)
AMD   129.15 (+0.61%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.53 (+1.19%)
CGC   0.76 (+5.07%)
GE   120.00 (+0.44%)
DIS   93.03 (+0.74%)
AMC   7.01 (+2.79%)
PFE   28.83 (+0.70%)
PYPL   59.37 (+1.52%)
XOM   99.22 (+0.81%)
S&P 500   4,590.72 (+0.11%)
DOW   36,157.16 (+0.11%)
QQQ   391.15 (+0.18%)
AAPL   194.71 (+0.23%)
MSFT   372.45 (+0.40%)
META   329.58 (+0.92%)
GOOGL   135.05 (-1.37%)
AMZN   146.56 (-0.22%)
TSLA   243.59 (+0.39%)
NVDA   475.58 (+2.06%)
NIO   7.48 (-0.13%)
BABA   72.12 (-0.29%)
AMD   129.15 (+0.61%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.53 (+1.19%)
CGC   0.76 (+5.07%)
GE   120.00 (+0.44%)
DIS   93.03 (+0.74%)
AMC   7.01 (+2.79%)
PFE   28.83 (+0.70%)
PYPL   59.37 (+1.52%)
XOM   99.22 (+0.81%)

GE HealthCare Technologies Stock Price, News & Analysis (NASDAQ:GEHC)

$67.84
+0.45 (+0.67%)
(As of 11:15 AM ET)
Compare
Today's Range
$67.05
$67.94
50-Day Range
$63.10
$73.71
52-Week Range
$53.00
$87.83
Volume
397,928 shs
Average Volume
2.98 million shs
Market Capitalization
$30.88 billion
P/E Ratio
20.19
Dividend Yield
0.18%
Price Target
$84.55

GE HealthCare Technologies MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
25.5% Upside
$84.55 Price Target
Short Interest
Bearish
4.22% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.82mentions of GE HealthCare Technologies in the last 14 days
Based on 15 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.99%
From $3.82 to $4.24 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.53 out of 5 stars

Medical Sector

134th out of 960 stocks

X - Ray Apparatus & Tubes Industry

2nd out of 6 stocks


GEHC stock logo

About GE HealthCare Technologies Stock (NASDAQ:GEHC)

GE HealthCare Technologies Inc. is a leading player in the medical industry, specializing in developing and manufacturing advanced healthcare technologies. With a strong commitment to improving patient outcomes and advancing medical science, the company has established itself as a trusted provider of innovative solutions for healthcare professionals worldwide.

The mission of GE HealthCare Technologies Inc. is to revolutionize healthcare through cutting-edge technology and collaboration. By leveraging its expertise in medical imaging, diagnostics, and biopharmaceutical manufacturing, the company aims to enable healthcare providers to deliver more precise diagnoses, personalized treatment options, and better patient care.

Headquartered in Chicago, Illinois, GE HealthCare Technologies Inc. has a global presence, with operations spanning multiple countries. Its products and services cater to various medical specialties, including radiology, cardiology, oncology, neurology, and more. The company's comprehensive portfolio encompasses medical imaging systems, diagnostic tools, pharmaceutical manufacturing equipment, and digital health solutions.

GE HealthCare Technologies Inc. serves a diverse customer base, including hospitals, clinics, research institutions, and pharmaceutical companies. The company has established strategic partnerships with leading healthcare providers and organizations to drive collaborative innovation and address pressing healthcare challenges.

GE HealthCare Technologies Inc. is led by a dynamic management team with extensive experience in the healthcare industry. The company's Chief Executive Officer (CEO) is Peter Arduini, a seasoned executive known for his strategic vision and operational expertise. Under his leadership, GE HealthCare Technologies Inc. has consistently pursued innovation and growth opportunities.

Jan Makela serves as the CEO of Imaging, overseeing the company's imaging solutions portfolio. With a strong background in medical technology and a focus on customer-centric innovation, Makela has played a crucial role in developing cutting-edge imaging technologies.

GE HealthCare Technologies Inc. has demonstrated strong financial performance in recent years, with consistent revenue growth and solid profit margins. The company's annual sales reached an impressive $18.34 billion in 2022, reflecting its position as a key player in the medical technology industry.

GE HealthCare Technologies Inc. has maintained a healthy financial position, with a favorable price-to-earnings ratio, indicating investor confidence in the company's future earnings potential. The forward-looking price-to-earnings-growth ratio of 3 suggests that the company is well-positioned for sustainable long-term growth.

The company's profitability is further highlighted by its impressive price-to-sales ratio, which indicates that investors are willing to pay a premium for GE HealthCare Technologies Inc.'s products and services. The company's strong cash flow position demonstrates the company's ability to generate substantial cash and reinvest in research and development initiatives.

GE HealthCare Technologies Inc. operates within the broader medical technology industry, encompassing various sub-sectors such as medical imaging, diagnostics, and biopharmaceutical manufacturing. This industry is characterized by rapid technological advancements, increasing demand for innovative solutions, and a growing emphasis on personalized patient care.

Competitors in the medical technology sector include established companies such as Siemens Healthineers, Philips Healthcare, Medtronic, and smaller niche players. GE Healthcare Technologies Inc. distinguishes itself through its diverse product portfolio, global presence, and commitment to continuous innovation.

The company's competitive advantage lies in its strong research and development capabilities, technological expertise, and strategic partnerships. These factors enable GE HealthCare Technologies Inc. to introduce cutting-edge solutions, improve patient outcomes and maintain a strong market position.

GE HealthCare Technologies Inc. is well-positioned to seize growth opportunities in the medical technology industry. The company can capitalize on several factors, including advancements in artificial intelligence and machine learning, increased demand for digital health solutions, and the rising prevalence of chronic diseases.

By leveraging its technological expertise, GE HealthCare can continue to develop innovative products and services that address these industry trends. Additionally, expanding into emerging markets, forging strategic partnerships, and pursuing acquisitions can provide avenues for further growth and market expansion.

While GE HealthCare Technologies Inc. has demonstrated resilience and growth potential, it faces risks and challenges inherent to the medical technology industry. Regulatory changes, evolving reimbursement models, and intense competition can impact the company's operations and profitability.

To mitigate these risks, GE HealthCare Technologies Inc. employs robust risk management strategies, including continuous monitoring of regulatory developments, diversification of product offerings, and proactive engagement with healthcare stakeholders. The company's strong research and development capabilities and focus on innovation allow it to adapt to evolving market dynamics and stay ahead of the competition.

GEHC Stock Price History

GEHC Stock News Headlines

GE stock surges to six-year high: What's behind the move? (GEHC)
General Electric stock hit a six-year closing high of $118.94, driven by a 78.67% gain this year. The company is spinning off its Vernova unit in Q2 2024
Recent Reports Are A Wake-Up Call For Investors
As the demand for lithium, an essential element to the energy revolution, increases globally, researchers are projecting a supply deficit as early as 2025. This has sparked a worldwide "gold rush" to find and develop new sources of this critical metal. Savvy investors are paying attention as mining companies race to meet this critical deadline.
Where GE HealthCare Techs Stands With Analysts
GE Healthcare: Unveiling Red Flags In Its Growth Story
Countries Are Investing Heavily Into Securing Energy Independence
There's a worldwide "arms race" for countries to secure lithium - the critical metal essential to powering the world's green energy transition. While the U.S. is now investing heavily into lithium production, the North American supply chain has fallen far behind. One company is on a mission to change that and make a previously remote area the next great lithium mining hub.
See More Headlines
Receive GEHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GE HealthCare Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 11/15 Dividend
10/19/2023
Last Earnings
10/31/2023
Dividend Payable
11/15/2023
Today
12/08/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
1/29/2024

Industry, Sector and Symbol

Industry
X - ray apparatus & tubes
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GEHC
Fax
N/A
Employees
50,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$84.55
High Stock Price Target
$97.00
Low Stock Price Target
$66.00
Potential Upside/Downside
+25.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
14 Analysts

Profitability

Net Income
$1.92 billion
Pretax Margin
12.81%

Debt

Sales & Book Value

Annual Sales
$19.28 billion
Cash Flow
$5.84 per share
Book Value
$20.59 per share

Miscellaneous

Free Float
454,287,000
Market Cap
$30.68 billion
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Peter J. Arduini (Age 58)
    President, CEO & Director
    Comp: $2.26M
  • Mr. Frank R. Jimenez Esq. (Age 58)
    General Counsel & Corporate Secretary
    Comp: $1.85M
  • Ms. Betty D. Larson (Age 47)
    Chief People Officer
    Comp: $1.78M
  • Mr. Jan Makela (Age 54)
    President & CEO of Imaging
    Comp: $955.06k
  • Mr. James K. Saccaro (Age 50)
    VP & CFO
  • Mr. George Andrew Newcomb (Age 56)
    Controller & Chief Accounting Officer
  • Dr. Taha Kass-Hout M.D. (Age 51)
    M.S., Chief Technology Officer
  • Mr. Thomas J. Westrick (Age 54)
    Chief Executive Officer of Patient Care Solutions
  • Mr. Kenneth R. Stacherski (Age 51)
    Chief Global Supply Chain & Service Officer
  • Mr. Elie Chaillot
    President & CEO of Intercontinental

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of GE HealthCare Technologies was last updated on Tuesday, November 28, 2023 at 11:36 AM.

Pros

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

  • GE HealthCare Technologies Inc. operates in multiple countries, providing a global market for its products, services, and digital solutions.
  • The company offers a wide range of products and services, including imaging systems, ultrasound solutions, patient care devices, and pharmaceutical diagnostics.
  • GE HealthCare Technologies Inc. is involved in the development and manufacture of innovative healthcare technologies, which can attract investors looking for companies at the forefront of medical advancements.
  • The company's focus on complementary digital solutions can provide additional revenue streams and enhance the overall value proposition for investors.
  • Recent developments and partnerships indicate a commitment to staying competitive and adapting to the evolving healthcare industry.

Cons

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

  • The X-ray apparatus and tubes industry, in which GE HealthCare Technologies Inc. operates, can be highly competitive, with potential challenges in market share and pricing.
  • Fluctuations in healthcare regulations and policies across different countries can impact the demand for GE HealthCare Technologies Inc.'s products and services.
  • The company's financial performance and stock price can be influenced by factors such as macroeconomic conditions, industry trends, and competitive pressures.
  • Investors should carefully consider the risks associated with investing in the healthcare sector, including regulatory uncertainties, reimbursement challenges, and potential litigation.
  • While recent developments show a commitment to innovation, there is always a level of uncertainty in the success and adoption of new products and technologies.














GEHC Stock Analysis - Frequently Asked Questions

Should I buy or sell GE HealthCare Technologies stock right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GEHC shares.
View GEHC analyst ratings
or view top-rated stocks.

What is GE HealthCare Technologies' stock price target for 2024?

14 Wall Street analysts have issued 1 year target prices for GE HealthCare Technologies' stock. Their GEHC share price targets range from $66.00 to $97.00. On average, they anticipate the company's share price to reach $84.55 in the next twelve months. This suggests a possible upside of 25.5% from the stock's current price.
View analysts price targets for GEHC
or view top-rated stocks among Wall Street analysts.

How have GEHC shares performed in 2023?

GE HealthCare Technologies' stock was trading at $59.00 at the beginning of 2023. Since then, GEHC stock has increased by 14.2% and is now trading at $67.39.
View the best growth stocks for 2023 here
.

Are investors shorting GE HealthCare Technologies?

GE HealthCare Technologies saw a increase in short interest in November. As of November 15th, there was short interest totaling 16,550,000 shares, an increase of 14.6% from the October 31st total of 14,440,000 shares. Based on an average daily volume of 2,800,000 shares, the days-to-cover ratio is currently 5.9 days. Approximately 4.2% of the shares of the company are short sold.
View GE HealthCare Technologies' Short Interest
.

When is GE HealthCare Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, January 29th 2024.
View our GEHC earnings forecast
.

How were GE HealthCare Technologies' earnings last quarter?

GE HealthCare Technologies Inc. (NASDAQ:GEHC) posted its quarterly earnings results on Tuesday, October, 31st. The company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.10. The company earned $4.82 billion during the quarter, compared to analysts' expectations of $4.80 billion. GE HealthCare Technologies had a net margin of 8.91% and a trailing twelve-month return on equity of 24.46%. The company's quarterly revenue was up 5.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.87 earnings per share.

How often does GE HealthCare Technologies pay dividends? What is the dividend yield for GE HealthCare Technologies?

GE HealthCare Technologies announced a quarterly dividend on Friday, September 22nd. Investors of record on Friday, October 20th will be given a dividend of $0.03 per share on Wednesday, November 15th. This represents a $0.12 annualized dividend and a yield of 0.18%. The ex-dividend date is Thursday, October 19th.
Read our dividend analysis for GEHC
.

Is GE HealthCare Technologies a good dividend stock?

GE HealthCare Technologies (NASDAQ:GEHC) pays an annual dividend of $0.12 per share and currently has a dividend yield of 0.17%. The dividend payout ratio is 3.57%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, GEHC will have a dividend payout ratio of 2.83% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for GEHC.

What guidance has GE HealthCare Technologies issued on next quarter's earnings?

GE HealthCare Technologies updated its FY23 earnings guidance on Tuesday, October, 31st. The company provided earnings per share guidance of $3.75-3.85 for the period, compared to the consensus estimate of $3.80.

Who are GE HealthCare Technologies' major shareholders?

GE HealthCare Technologies' stock is owned by a variety of retail and institutional investors. Top institutional investors include FMR LLC (1.89%), Invesco Ltd. (1.11%), Newport Trust Company LLC (1.10%), Bank of New York Mellon Corp (0.96%), Northern Trust Corp (0.92%) and Morgan Stanley (0.74%). Insiders that own company stock include H Lawrence Culp Jr, Jan Makela, Kevin Michael O'neill and Roland Rott.
View institutional ownership trends
.

How do I buy shares of GE HealthCare Technologies?

Shares of GEHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:GEHC) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -